Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

Surbhi Sidana; Dragan Jevremovic; Rhett P. Ketterling; Nidhi Tandon; Patricia T. Greipp; Linda B. Baughn; Angela Dispenzieri; Morie A. Gertz; Sundararajan Vincent Rajkumar; Shaji K. Kumar

doi:10.1002/ajh.25420

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

Surbhi Sidana, Dragan Jevremovic, Rhett P. Ketterling, Nidhi Tandon, Patricia T. Greipp, Linda B. Baughn, Angela Dispenzieri, Morie A. Gertz, Sundararajan Vincent Rajkumar, Shaji K. Kumar

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	E117-E120
Journal	American journal of hematology
Volume	94
Issue number	5
DOIs	https://doi.org/10.1002/ajh.25420
State	Published - May 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25420

Cite this

@article{993fb572f1ed4ec99c7304d31b5b3f98,

title = "Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma",

author = "Surbhi Sidana and Dragan Jevremovic and Ketterling, {Rhett P.} and Nidhi Tandon and Greipp, {Patricia T.} and Baughn, {Linda B.} and Angela Dispenzieri and Gertz, {Morie A.} and Rajkumar, {Sundararajan Vincent} and Kumar, {Shaji K.}",

note = "Funding Information: SS: Honoraria/consultancy: Janssen; AD: Consultant for Takeda; Research funding from Celgene, Takeda, Janssen; GlaxoSmithKline, Alnylam, and Pfizer; MAG: Honoraria/consultancy from Ionis, Alnylam, Prothena, Celgene, Janssen, Specytrum, Annexon, Apellis, Amgen, Medscape, Abbvie, Research to Practice, Physcians Education Resource and Teva; SKK: Research Funding and membership on an entity's Board of Directors or advisory committees: AbbVie, Celgene, Janssen KITE, Merck. Membership on an entity's Board of Directors",

year = "2019",

month = may,

doi = "10.1002/ajh.25420",

language = "English (US)",

volume = "94",

pages = "E117--E120",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

AU - Sidana, Surbhi

AU - Jevremovic, Dragan

AU - Ketterling, Rhett P.

AU - Tandon, Nidhi

AU - Greipp, Patricia T.

AU - Baughn, Linda B.

AU - Dispenzieri, Angela

AU - Gertz, Morie A.

AU - Rajkumar, Sundararajan Vincent

AU - Kumar, Shaji K.

N1 - Funding Information: SS: Honoraria/consultancy: Janssen; AD: Consultant for Takeda; Research funding from Celgene, Takeda, Janssen; GlaxoSmithKline, Alnylam, and Pfizer; MAG: Honoraria/consultancy from Ionis, Alnylam, Prothena, Celgene, Janssen, Specytrum, Annexon, Apellis, Amgen, Medscape, Abbvie, Research to Practice, Physcians Education Resource and Teva; SKK: Research Funding and membership on an entity's Board of Directors or advisory committees: AbbVie, Celgene, Janssen KITE, Merck. Membership on an entity's Board of Directors

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85061179930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061179930&partnerID=8YFLogxK

U2 - 10.1002/ajh.25420

DO - 10.1002/ajh.25420

M3 - Letter

C2 - 30680770

AN - SCOPUS:85061179930

SN - 0361-8609

VL - 94

SP - E117-E120

JO - American journal of hematology

JF - American journal of hematology

IS - 5

ER -

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this